Bispecific Antibodies market Size, Share, Trends by 2035

Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder

Roots Analysis has announced the addition of “Bispecific Antibodies Market, 2023-2035” report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the market for such therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
 An executive summary of the key insights captured during our research
 A brief introduction to bispecific antibodies, highlighting their historical background, as well as information on their structure, different types available, unique antibody formats, mechanisms of action of various drugs and their applications
 A detailed review of the market landscape of over 220 bispecific antibodies that are either approved or being evaluated in different stages of clinical development
 An in-depth assessment of the market landscape of over 180 bispecific antibodies that are currently being evaluated in preclinical studies
 An insightful analysis, highlighting the contemporary market trends in the bispecific antibody therapeutics domain, through six different graphical representations
 A detailed assessment of over 80 technology platforms being developed / used by various drug developers for the production of bispecific antibody therapeutics
 An in-depth analysis of big pharma players engaged in this domain, featuring insightful spider web analyses and heat map analyses
 Elaborate profiles of prominent drug developers engaged in the development of bispecific antibodies, featuring a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key members of the executive team, financial details / information (if available), drug portfolio, recent developments and an informed future outlook
 An insightful analysis of various partnerships inked between stakeholders engaged within the bispecific antibody therapeutics domain, during the period 2016-2023
 A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies, along with information on various contract manufacturing organizations (CMOs) and contract research organizations (CROs) engaged in this domain
 An in-depth analysis of ongoing and planned clinical trial studies related to bispecific antibody therapeutics, which were registered till April 2023
 A review of regulatory guidelines issued by the ICH, WHO and FDA for the development of bispecific antibodies. In addition, it provides details related to the responses of various pharmaceutical industries to the FDA guidelines
 A review of different channels used for promoting marketed bispecific antibodies, elaborating on the various promotional strategies being adopted by developers of two approved bispecific antibodies (chosen based on their popularity in this domain), namely Blincyto™ and Hemlibra®
 A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework, featuring a qualitative Harvey ball analysis highlighting the relative impact of each SWOT parameter on the overall market
 A comprehensive market forecast analysis, including future sales projections of bispecific antibodies that are either marketed or under phase III of clinical development, till the year 2035, presenting a detailed market segmentation on various segments:

 Therapeutic Area
 Autoimmune Disorders
 Genetic Disorders
 Hematological Malignancies
 Ophthalmic Disorders
 Skin Cancers
 Solid Tumors

 Mechanism of Action
 Cytokines Retargeting / Neutralization
 Dual Ligands Blocking
 Resistance Factors Co-targeting
 Targeting Tumor Angiogenesis
 T-Cell Retargeting / Activation
 Others

 Target Antigen
 C5-Albumin
 CD20 x CD3
 CD3 x BCMA
 CD3 x CD19
 EGFR x cMET
 EpCAM x CD3
 Factor IXa x Factor X
 gp100 x CD3
 HER2 x HER2
 PD-1 x CTLA-4
 PD-L1 x TGFβ
 TNF-α x HSA
 VEGF x DLL4
 VEGF-A x ANG2

 Antibody Format
 Asymmetric
 Fragments

 Key Players
 Akeso Biopharma
 Alexion
 Amgen
 Genmab
 Immunocore
 Janssen Research & Development
 Linton Pharm
 Merck
 OncXerna Therapeutics
 Pfizer
 Roche
 Taisho Pharmaceutical
 Zymeworks

 Key Geographical Regions
 Asia
 Europe
 North America
 Rest of the World

Key companies covered in the report
 Akeso Biopharma
 Alphamab Oncology
 Amgen
 Merck
 Regeneron
 Roche
 Xencor

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services
Top 10 Quantum Computing Companies Transforming Drug Discovery

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bispecificantibodiesmarket #bispecificantibodiesmarketsize #bispecificantibody #bispecificantibodies #approvedbispecificantibodies

Fill Finish Biopharmaceuticals market, Industry Analysis, and Forecast to 2035

Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

The financial opportunity within the biologics fill finish services market has been analysed across the following segments:

 Type of Packaging Container
 Ampoules
 Cartridges
 Syringes
 Vials

 Type of Biologic
 Antibodies
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Proteins / Peptides
 Vaccines
 Others

 Therapeutic Area
 Oncological Disorders
 Autoimmune Disorders
 Infectious Diseases
 Cardiovascular Disorders
 Other Disorders

 Scale of Operation
 Preclinical / Clinical
 Commercial

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
 AbbVie Contract Manufacturing
 Asymchem
 BioReliance
 Boehringer Ingelheim BioXcellence
 Catalent Biologics
 Charles River Laboratories
 Fareva
 Fresenius Kabi
 Glaxo SmithKline
 Hetero Drugs
 Intas Pharmaceuticals
 Lonza
 Patheon
 Pierre Fabre
 Recipharm
 Samsun Biologics
 Syngene
 Takara Bio
 Wacker Biotech
 WuXi AppTec
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Biologics Fill / Finish Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America

7. Biologics Fill / Finish Service Providers in Europe

8. Biologics Fill / Finish Service Providers in Asia-Pacific

9. Recent Partnerships

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

14. Regional Capability Assessment

15. Biologics Fill Finish Market Sizing and Opportunity Analysis

16. Future Growth Opportunities

17. Case Study: Robotic Systems in Fill / Finish Operations

18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

19. Concluding Remarks

20. Executive Insights

21. Appendix 1: Tabulated Data

22. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

News article
women's digital health market

Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
TIL Therapies: A New Paradigm in Cancer Treatment

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#fillfinishbiopharmaceuticalsmarketgrowth#fillfinishbiopharmaceuticalsmarkettrends#fillfinishmarket#fillfinishmanufacturingmarket#fillfinishservicemarket

Medical Device Coating market Analysis and Trends by 2023-2035

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

Roots Analysis has announced the addition of “Medical Device Coating Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of medical coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Amongst other elements, the report includes:
 A detailed executive summary of the insights captured during our research.
 A detailed assessment of the current market landscape of medical device coating providers.
 Detailed competitiveness analysis of various medical device coating providers.
 A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.
 Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.
 An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.
 An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.
 A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices

 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings

 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large

 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/medical-devi

Learn from experts: do you know about these emerging industry trends?
Introduction To Exosome Therapeutics
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#medicaldevicecoatingmarket #medicaldevicecoatingmarketsize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies

Automated Liquid Handling Systems market Research Report by 2023, Forecast till 2035

The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling

Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.”

The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes:
 An executive summary of the insights captured during our research.
 A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems.
 A detailed assessment of the current market landscape of automated pipetting systems, based on several relevant parameters.
 A detailed competitiveness analysis of automated pipetting system providers based on several relevant parameters
 Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated pipetting systems across North America, Europe and Asia-Pacific and rest of the world.
 A detailed assessment of the current market landscape of automated microplate washers, based on several relevant parameters.
 A detailed competitiveness analysis of automated microplate washer providers based on several relevant parameters.
 Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated microplate washers across North America, Europe and Asia-Pacific and rest of the world.
 A detailed analysis of partnerships inked between stakeholders engaged in this industry since 2018.
 An in-depth analysis of various patents that have been filed / granted related to automated liquid handling systems since 2018.
 A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Automated Pipetting Systems Market
 Pipetting Technology
 Contact Technology
 Air Displacement Technology
 Piston / Positive Displacement Technology
 Acoustic Technology
 Free-jet Technology

 Modality
 Fixed Tips
 Disposable Tips

 Type of Instrument
 Standalone
 Individual Benchtop Workstation
 Multi Instrument Systems
 Others

 Applications
 Serial Dilution
 Plate Replication
 PCR / qPCR Setup
 Plate Reformatting
 High-throughput Screening
 Whole Genome Amplification
 Cell Culture
 Other Applications

 End User
 Biotechnology and Pharmaceutical Companies
 Academic and Government Research Institutes
 Hospitals and Diagnostic Centers
 Other End Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Automated Microplate Washers Market
 Washing Technology
 Ultrasonic Technology
 Acoustic Technology
 Centrifugal Technology

 Application
 ELISA
 Cell-based Assays
 Bead Washing
 Other Applications

 End-user
 Biotechnology and Pharmaceutical Companies
 Academic and Government Research Institutes
 Hospitals and Diagnostic Centers
 Other End Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America


Key companies covered in the report
 Agilent Technologies
 Beckman Coulter Life Sciences
 Eppendorf
 Hamilton Robotics
 MyGenostics
 Tecan
 Thermo Fisher Scientific

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/automated-li

News article
Global Cell Free Expression Market

Learn from experts: do you know about these emerging industry trends?
Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#automatedliquidhandlingsystemsmarket #automatedliquidhandlingsystemsmarketsize #automatedliquidhandling #automatedliquidhandler #hamiltonliquidhandler

Cell Free Expression market, Size and Share by 2035

The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.”

The cell free market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:
 An executive summary of insights captured during our research.
 A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique
 A detailed assessment of the current market landscape of cell free expression service providers.
 A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.
 A comprehensive company competitiveness analysis of cell free expression service providers.
 A product competitiveness analysis of cell free expression kits based on various relevant parameters.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.
 Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).
 A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.
 An analysis of the funding and investments made in the cell free expression market, since 2018.
 An in-depth analysis of various patents that have been filed / granted related to cell free systems since 2015.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Type of Cell Free System
• Crude Cell Lysate-based Systems
• Reconstituted Systems

 Type of Host Organism
• Microbial Cell Free Expression System
• Mammalian Cell Free Expression Systems
• Plant-based Cell Free Expression Systems
• Other Cell Free Expression Systems

 Type of Expression Method
• Coupled Transcription and Translation Method
• Translation Method

 End-User
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Other End-Users

 Key Geographical Regions
• North America
• Europe
• Asia Pacific
• Rest of the World

Key companies covered in the report
 BioLinker
 biotechrabbit
 CellFree Sciences
 Creative Biolabs
 CUSABIO
 Daicel Arbor Biosciences
 LenioBio
 Promega
 Thermo Fisher Scientific
 Touchlight

For additional details, please visit https://www.rootsanalysis.com/....reports/cell-free-ex

Learn from experts: do you know about these emerging industry trends?
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cellfreeexpressionmarkettrends #cellfreeexpressionmarketgrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem